Article Versions Notes

Wu Y, Zhang R, Yuan G, He L, Dai X, Chuan H, Wang M, Liu J, Xu L, Liao G, et al. Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient. Viruses. 2024; 16(11):1761. https://doi.org/10.3390/v16111761

Wu, Yanan, Runfang Zhang, Guangbo Yuan, Lingyu He, Xiaohu Dai, Hongyun Chuan, Mingqing Wang, Jing Liu, Lilan Xu, Guoyang Liao, and et al. 2024. "Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient" Viruses 16, no. 11: 1761. https://doi.org/10.3390/v16111761

Wu, Y., Zhang, R., Yuan, G., He, L., Dai, X., Chuan, H., Wang, M., Liu, J., Xu, L., Liao, G., Li, W., & Zhou, J. (2024). Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient. Viruses, 16(11), 1761. https://doi.org/10.3390/v16111761